Restrictionsapply
Planets Sun
copayimage Restrictionsapply Save now
Skip Navigation LinksHome > Diabetes and Insulin > Other Delivery Systems

Other Delivery Systems for NovoLog® Insulin

In addition to the NovoLog® FlexPen® (insulin aspart [rDNA origin] injection) and NovoLog® in a pump, there are several other insulin delivery devices. Many are discreet and ready to use in just a few steps.

The Latest Novo Nordisk Reusable Insulin Pen:
NovoPen Echo®

novopen

NovoPen Echo® is the first and only insulin pen with both half-unit dosing and a memory function, and you can pick from a variety of fun skin designs.

Learn more

NovoPen® Junior

  • The precision of half-unit dosing increments
  • For use with NovoLog® 3-mL (300-unit) PenFill® cartridges and NovoFine® disposable needles*

NovoPen Echo® is replacing NovoPen® Junior, which—like NovoPen® 3 and PenMate®—will no longer be available at the pharmacy. However, you can continue to use your NovoPen® Junior, NovoPen® 3, and PenMate®. If you have any questions about the discontinuation of these products, please call 1-800-727-6500. Ask your doctor about NovoPen Echo® and how it can help you (or your loved one) reach your diabetes goals.

NovoFine® needles fit all major insulin devices

The NovoFine® 32G Tip (6 mm) needle is the thinnest needle from Novo Nordisk available in the United States. It is as thin as two hairs.

The majority of people studied using the NovoFine® 32G Tip needle experienced little or no pain.†

Needles are sold separately and may require a prescription in some states.

Vial and syringe

NovoLog® is available in a 10 mL vial, 100 units/mL (U-100) of NovoLog®.

* PenFill® cartridges sold separately.
Multicenter, randomized, open-label, 2-period, crossover trial in insulin-treated patients with diabetes (type 1 or type 2). Patients were randomized to self administer insulin injections with one needle type followed by the alternative, each for 7 to 14 days. The 2 needle types used were NovoFine® 32-gauge tip x 6 mm and NovoFine® 30-gauge tip x 8 mm.


Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Who should not use NovoLog®?

Do not use NovoLog® if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

What should I tell my health care provider before taking NovoLog®?

About all of your medical conditions, including liver, kidney, or heart problems.
If you are pregnant, breastfeeding, or plan to do either.
About all prescription and nonprescription medicines you take, including supplements, as your dose may need to change.

How should I take NovoLog®?

Eat a meal within 5 to 10 minutes after using NovoLog®, a fast-acting insulin, to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after your injection or bolus pump infusion.
Do not mix NovoLog® with any other insulin when used in a pump or with any insulin other than NPH when used with injections by syringe.
Do not change your dose or type of insulin unless you are told to by your health care provider.
Do not share needles, insulin pens, or syringes.
Check your blood sugar levels as directed by your health care provider.

What should I consider while using NovoLog®?

Alcohol, including beer and wine, may affect your blood sugar.
Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your health care provider if you often have low blood sugar or no warning signs of low blood sugar.

What are the possible side effects of NovoLog®?

Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.
Serious allergic reactions may occur. Get medical help right away, if you develop a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.
Other side effects include injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, vision changes, low potassium in your blood, and weight gain.

For more information, please click here for complete NovoLog® Prescribing Information.

NovoLog® is a prescription medicine.

Talk to your doctor about the importance of diet and exercise in your treatment plan.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PPA Logo Rev
If you need assistance with prescription drug costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.

Selected Important Safety Information

What are the possible side effects of NovoLog®?

• Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.

• Other side effects include injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, vision changes, low potassium in your blood, and weight gain.

Please click here for additional Important Safety Information

Email to a Friend:

email icon

To(;):

From:

Message: